Role of ADP and thromboxanes in human thrombus formation in ex vivo models

Platelets

Volumn 8, Issue 6, 1997, Pages 385-390

  Sakariassen, K S ^a   Orning L ^b   Stormorken, H ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTICOAGULANT AGENT; CLOPIDOGREL; LINOTROBAN; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBOXANE; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT;

ADULT; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD FLOW; BLOOD VESSEL TONE; BLOOD VESSEL WALL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOGENESIS; VASOCONSTRICTION; VASODILATATION;

EID: 0031449293     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109777069     Document Type: Review

References (32)

1. Caprie Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-39.
2. Schomig A, Neumann F-J, Kastrati A, Schulen H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth E-M, Richardt G, Alt E, Schmitt C. Ulm K. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Eng J Med 1996; 334: 1084-9.
3. Hennekens CH, Peto R, Hutchinson GB, Doll R. An overview of the British and American aspirin studies. N Eng J Med 1988; 318: 923-4.
4. Roald HE, Ørvim U, Bakken IJ, Barstad RM, Kierulf P, Sakariassen KS. Modulation of thrombotic responses in moderately stenosed arteries by cigarette smoking and aspirin ingestion. Arterioscler Thromb 1994; 14: 617-21.
5. Barstad RM, Ørvim U, Hamers MJAG, Tjønnfjord G, Brosstad F, Sakariassen KS. Reduced effect of aspirin on thrombus formation at high shear and disturbed laminar blood flow. Thromb Haemostas 1996; 75: 827-32.
6. 2 receptor antagonist with antithrombotic activity in humans at arterial blood flow conditions. Thromb Haemostas 1994; 71: 103-9.
7. Roald HE, Barstad RM, Kierulf P, Skjørten F, Dickinson JP, Kieffer G, Sakariassen KS. Clopidogrel, a platelet inhibitor which inhibits thrombogenesis in human non-anticoagulated blood independently of the blood flow conditions. Thromb Haemostas 1994; 71: 665-72.
8. Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, Schnaper HW, LeWinter MM, Linares E, Pouget JM, Sabharwal SC, Chesler E, DeMots H. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Eng J Med 1983; 309: 396-403.
9. Theroux P, Quimet H, McCans J, Latour JG, Joly P, Levy G, Pelletier E, Juneau M, Stasiak J, de Guise P, Pelletier GB, Rinzler D, Waters DD. Aspirin, heparin or both to treat unstable angina. N Eng J Med 1989; 319: 1105-11.
10. Coller B. GPIIb/IIIa antagonists: pathophysiologic and therapeutic insights from studies of c7E3 Fab. Thromb Hemostas 1997; 78: 730-5.
11. Bunting S, Gryglewski RJ, Moncada S, Vane JR. Arterial walls generate from prostaglandin endoperoxides a substance which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins 1976; 12: 897-906.
12. Moncada S, Vane JR. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxanes A2, and prostacyclin. Pharmacol Rev 1979; 30: 293-331.
13. Kaul S, Waack BJ, Padgett RC, Brooks RM, Heistad DD. Interaction of human platelets and leukocytes in modulation of vascular tone. Am J Physiol 1994; 266: H1706-14.
14. Kaul S, Padgett RC, Heistad DD. Role of platelets and leukocytes in modulation of vascular tone. Ann N Y Acad Sci 1994; 714: 122-35.
15. Sakariassen KS, Joss R, Muggli R, Kuhn R, Tschopp TB, Sage H. Baumgartner HR. Collagen type III induced ex vivo thrombogenesis in humans: role of platelets and leukocytes in deposition of fibrin. Arteriosclerosis 1990; 19: 276-84.
16. Diquelou A, Lemozy S, Dupoy D, Boneu B, Sakariassen KS, Cadroy Y. Effect of blood flow on thrombin formation: influence of the nature of procoagulant and non-procoagulant surfaces. Blood 1994; 84: 2206-13.
17. Barstad RM, Roald HE, Cui W, Turitto VT, Sakariassen KS. A perfusion chamber developed to investigate thrombus formation and shear profiles in flowing native human blood at the apex of well-defined stenoses. Arterioscler Thromb 1994; 14: 1984-91.
18. Humbert M, Nurden P, Bihour C, Pasquet J-M, Winckler J, Heilmann E, Savi P, Herbert J-M, Kunicki TJ, Nurden AT. Ultrastructural studies of platelet aggregates from human subjects receiving clopidiogrel and from a patient with an inherent defect of an ADP-dependent pathway of platelet activation. Blood 1996; 16: 1532-43.
19. Calvete JJ. Clues for understanding structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex. Thromb Haemostas 1994; 72: 1-15.
20. Roald HE, Sakariassen KS. Axial dependence of collagen-induced thrombus formation in flowing non-anticoagulated human blood: anti-platelet drugs which impairs thrombus growth and increases platelet - collagen adhesion. Thromb Haemostas 1995; 73: 128-32.
21. Weiss HJ, Lages B, Hoffmann T, Turitto VT. Correction of the platelet adhesion defect in δ-storage pool deficiency at elevated hematocrit - possible role of adenosine diphosphate. Blood 1996: 87: 4214-22.
22. Zwaal RFA, Schroit AJ. Pathophysiology implications of membrane phospholipid assymetry in blood cells. Blood 1997; 89: 1121-32.
23. Weiss HJ, Lages B. Platelet prothrombinase activity and intracellular calcium responses in patients with storage pool deficiency, glycoprotein IIb - IIIa deficiency, or impaired platelet coagulant activity - a comparison with the Scott syndrome. Blood 1997; 89: 1599-611.
24. 2) inhibits platelet adhesion and thrombus formation on subendothelium. Blood 1979; 53: 244-50.
25. Barstad RM, Stormorken H, Örning L, Stephens RW, Petersen LB, Kierulf P, Sakariassen KS. Reduced thrombus formation in native blood of homozygous factor VII deficient patients at high arterial wall shear rate. Blood 1994; 84: 3371-7.
26. Fressinaud E, Sakariassen KS, Rotschild C, Baumgartner HR. Meyer D. Shear rate dependent decrease of thrombus growth on collagen in non-anticoagulated blood from patients suffering from von Willebrand disease and hemophilia A. Blood 1992; 80: 988-94.
27. Ørvim U, Barstad RM, Vlasuk GP, Sakariassen KS. Effect of selective factor Xa inhibition on arterial thrombus formation triggered by tissue factor/factor VIIa or collagen in an ex vivo model of human shear dependent thrombus formation. Arterioscl Thromb Vasc Biol 1995; 15: 2188-94.
28. Holme PA, Ørvim U, Hamers MJAG, Solum N-O, Brosstad FR, Barstad RM, Sakariassen KS. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscl Thromb Vasc Biol 1997; 17: 646-53.
29. Moake JL, Turner NA, Stathopoulos NA, Nolasco L, Hellums JD. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 1988; 71: 1366-74.
30. Gaarder A, Jonsen J, Laland S, Hellem A, Owren PA. Adenosine diphosphate in red cells as a factor in the adhesiveness of blood platelets. Nature 1961; 192: 531-2.
31. Gachet C, Hechler B, Leon C, Vial C, Ohlmann P, Cazenave J-P. Purinergic receptors on blood platelets. Platelets 1996; 7: 261-7.
32. Pearson JO, Carleton JS, Gordon JL. Metabolism of adenosine nucleotides by ectoenzymes of vascular endothelial cells and smooth muscle. Biochem J 1980; 190: 421-9.